News und Analysen
DGAP-HV: Merck KGaA: Bekanntmachung der Einberufung zur Hauptversammlung am 22.04.2022 in Darmstadt (virtuelle Hauptversammlung) mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
Deciphera Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Tucker Kelly, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Barclays Global
Form 8.3 - The Vanguard Group, Inc.: NortonLifeLock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLifeLock Inc.
Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric Participants
Pfizer Inc. (NYSE: PFE) announced today that it has initiated a Phase 2/3 study, EPIC-PEDS (Evaluation of Protease Inhibition for COVID-19 in Pediatric Patients), to evaluate the safety
Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric Participants
Pfizer Inc. (NYSE: PFE) announced today that it has initiated a Phase 2/3 study, EPIC-PEDS (Evaluation of Protease Inhibition for COVID-19 in Pediatric Patients), to evaluate the safety
DGAP-News: Deutsche Post AG: Announcement pursuant to Art. 5 para 1 of Regulation (EU) No. 596/2014 in conjunction with Art. 2 para 1 of the Delegated Regulation (EU) 2016/1052 of the Commission
DGAP-News: Deutsche Post AG: Bekanntgabe gemäß Art 5 Abs. 1 der Verordnung (EU) Nr. 596/2014 i.V.m. Art. 2 Abs. 1 der Del. VO (EU) 2016/1052 der Kommission (in der jeweils gültigen Fassung)
NICE CXone Gets Top Honors for Contact Center Platforms in Metrigy Research
NICE (Nasdaq: NICE) today announced that it has been recognized as a MetriStar Top Provider in the Contact Center Platform category from among 16 companies evaluated. Based on a ranking of
Transgene to Present New Positive Preliminary Phase I Data on TG4050 (myvac® platform), its Individualized Therapeutic Cancer Vaccine, at AACR 2022
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer will be presenting a poster with
Transgene and BioInvent Announce Poster Presentation on BT-001, a Novel Antibody-encoding Oncolytic Virus, at AACR 2022
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (“BioInvent”) (Nasdaq
DGAP-News: Continental Generates Profit and Expects Further Improvement in Results
DGAP-News: Continental erzielt Gewinn und erwartet weitere Ergebnissteigerung
DGAP-News: Nordex Group: preliminary annual figures for 2021 confirm guidance
DGAP-News: Nordex Group: preliminary annual figures for 2021 confirm guidance
DGAP-News: Nordex Group: Vorläufige Jahreszahlen 2021 bestätigen Prognose
DGAP-News: Nordex Group: Vorläufige Jahreszahlen 2021 bestätigen Prognose
DGAP-News: Klöckner & Co SE delivers best operating income in fiscal year 2021 since IPO
DGAP-News: Klöckner & Co erzielt im Geschäftsjahr 2021 das beste operative Ergebnis seit Börsengang
DGAP-News: Siltronic AG closes fiscal 2021 with strong earnings - dividend of EUR 3.00 per share proposed
DGAP-News: Siltronic AG schließt das Geschäftsjahr 2021 mit einem starken Ergebnis ab - Dividende von EUR 3,00 je Aktie vorgeschlagen
DGAP-News: Siltronic AG closes fiscal 2021 with strong earnings - dividend of EUR 3.00 per share proposed
DGAP-News: Siltronic AG schließt das Geschäftsjahr 2021 mit einem starken Ergebnis ab - Dividende von EUR 3,00 je Aktie vorgeschlagen